Application of SUSD2 in preparation of kit for diagnosis and/or prognostic judgement of high-grade serous ovarian carcinoma
A prognostic judgment, ovarian cancer technology, applied in the field of biomedicine, can solve the problems of low long-term survival rate and poor prognosis
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0033] 1. Test method:
[0034] We collected archival wax blocks of surgical specimens from 55 patients with fimbria and 306 patients with high-grade serous ovarian cancer from 2007-2013. Using a semi-automatic tissue chip punching machine to make 3 TMA tissue chips to ensure large samples, high throughput and standardization of immunohistochemistry. Each block contains fimbria and high-grade serous ovarian carcinoma.
[0035] Tissue Microarray (TMA) technology is a microarray tissue sheet made by neatly arranging dozens to hundreds or even more tissue samples on a glass slide. Through immunohistochemistry, in situ hybridization, etc., high-throughput acquisition of genomics and proteomics expression information based on morphology has been achieved on tissue sections. Tissue chip technology has been widely used in tumor research to study the changes of genes and proteins in different development stages of tumors, the evaluation of prognosis, the evaluation of molecular mark...
Embodiment 2
[0074] The method of the embodiment of the present invention 1 is adopted to detect the tissue of the wax block specimen, and the microscopic examination results are as follows: image 3 and Figure 4 shown. in, image 3 The expression of SUSD2 in the tissue section shown is relatively high, and there are obvious brown particles on the cell membrane, which is a positive result of SUSD2 detection, and the result of pathological examination is high-grade serous ovarian cancer.
[0075] Figure 4 The expression level of SUSD2 in the shown tissue section is low, without obvious brownish-yellow granules, which is a negative result of SUSD2 test, and the result of pathological test is negative for lymph node metastasis.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


